Background. Simple tumor enucleation (TE) showed excellent oncologic results in large retrospective series. No study has compared oncologic outcomes after TE and radical nephrectomy (RN) for the treatment of pT1 renal cell carcinoma (RCC). The aim of the present study is to compare the oncologic outcomes after TE and RN in pT1 RCCs. Methods. We retrospectively analyzed 475 patients who underwent TE or RN for pT1 RCC, N0, M0, between 1995 and 2007 . TE was performed in 332 patients and RN in 143. Local recurrence, progression-free survival (PFS), and cancer-specific survival (CSS) were the main outcomes of this study. The Kaplan-Meier method was used to calculate survival functions, and differences were assessed with the log rank statistic. Univariate and multivariate Cox regression models were also used. Results. The 5-and 10-year PFS estimates were 91.3 and 88.7% after RN and 95.3 and 92.8% after TE (P = NS), respectively. The 5-and 10-year CSS estimates were 92.1 and 89.4% after RN and 94.4% (5-and 10-year CSS) after TE (P = NS), respectively. No statistically significant differences between RN and TE were found after adjusting CSS probabilities according to age at surgery, grade, stage, or clear cell subtype. Surgical treatment was not a predictor of PFS or CSS by both univariate and multivariate analyses. The potential limitation of this study is that the data originate from a retrospective review. Conclusions. TE can achieve oncologic results similar to those of RN for the treatment of pT1 RCCs, provided tumors are carefully selected on the basis of their safe and complete removal.
In the past two decades, several authors have demonstrated the oncologic equivalence between partial nephrectomy (PN) and radical nephrectomy (RN) in the treatment of T1 renal cell carcinoma (RCC). [1] [2] [3] [4] [5] [6] Currently, PN is the standard treatment for solitary RCC up to a diameter of 7 cm, whenever technically feasible, and the excision of the tumor with a substantial margin of normal renal parenchyma is considered the standard technique for PN to minimize the risk of local recurrence. 7, 8 Simple tumor enucleation (TE) consists of excising the tumor by blunt dissection following the natural cleavage plane between the peritumoral capsule and the renal parenchyma without removing a visible rim of healthy renal tissue. Recently, the urologic current opinion has changed from a wide skepticism against TE to a wider level of acceptance on the basis of the lack of correlation between the width of the resection margin and the risk of disease progression or local recurrence and on larger retrospective series on TE with longer follow-up. [9] [10] [11] [12] [13] [14] Nevertheless, to date, to our knowledge, no study has compared oncologic outcomes after TE and RN for pT1 RCCs. The objective of this retrospective study was to compare the risk of local recurrence, progression-free survival (PFS), and cancer-specific survival (CSS) after TE and RN in pT1 RCCs.
PATIENTS AND METHODS
We retrospectively reviewed the clinical and pathologic data of 475 consecutive patients who had kidney surgery between 1995 and 2007 for localized RCC up to 7 cm in diameter confirmed at pathologic analysis, with no pre-or intraoperative suspicion of positive nodes and free from distant metastases before surgery (M0). The preoperative evaluation for all patients included ultrasound of the urinary tract, computed tomography (CT) of the abdomen, and chest x-ray or alternatively CT scan of the thorax. For the objective of the study, patients with positive nodes and/or systemic metastases were excluded from analysis. A computerized database was generated for data transfer. Performance status was assigned according to Eastern Cooperative Oncology Group (ECOG) criteria. 15 RN was performed in 143 patients (30.1%), and open TE was performed in the remaining 332 (69.9%). Surgical procedures were performed by several surgeons according to the standard criteria for RN, i.e., extrafascial dissection of the kidney. Because none of these patients had pre-or intraoperative suspicion of metastatic node disease, lymph node dissection was limited to the nodes located at the hilar site, if present. Disease was found to be N0 at pathologic analysis.
TE has been defined as tumor excision by using the natural cleavage plane between the tumor and normal parenchyma. After kidney capsule skeletonization, the renal pedicle is carefully isolated and usually controlled with vascular clamps before TE. Warm ischemia was used in 255 cases: the mean ischemic time was 16.5 (range 8-32) minutes. We avoided renal ischemia only for small, exophytic, polar lesions (62 patients). Renal hypothermia with slush was rarely used during this period when prolonged ischemia times ([30 min) were anticipated (15 patients, mean ischemia time 25 minutes, range 17-45 min). Then the kidney capsule is sharply incised starting 1-2 mm away from the lesion toward the tumor capsule, and when the capsule is visually reached, the tumor is enucleated by blunt dissection, with no visible rim of normal parenchyma. The visible bleeding vessels and incidental opening of the calyces are ligated with a running suture with 4-0 monofilament. The parenchymal defect is closed with horizontal interrupted sutures after sealant (Cyanoacrylate glue, Tachosil, FloSeal) and Tabotamp bolster apposition.
Imperative TE was performed in patients with tumors involving anatomically or functionally solitary kidneys. TE and RN were performed, according to the surgeon's preference and judgment of feasibility.
Pathologic Evaluation
All surgical specimens were processed according to standard pathologic procedures. Tumors were staged according to the American Joint Committee on CancerUnion Internationale Contre le Cancer tumor, node, metastasis system (TNM) classification. 16 The Heidelberg and Fuhrman classifications were used to assign the histologic type and nuclear grade, respectively. 17, 18 Moreover, the presence of sarcomatoid differentiation and margin status were evaluated.
Follow-up Regimen
The follow-up visits consisted of a history, physical examination, routine blood analysis, serum chemistry studies, and chest radiography, in association with either ultrasound or CT of the abdomen, performed alternatively. Follow-up visits were scheduled every 3-4 months for the first year after surgery, every 6 months from the second to the fifth years, and then annually thereafter.
Elective bone scan, chest CT, and magnetic resonance imaging were used when clinically indicated. In most cases (60 patients), cause of death was determined by the treating physicians and by chart review corroborated by death certificates, if needed. In 17 patients, the cause of death was defined by death certificates alone.
Statistical Analysis
Continuous variables were reported as mean ± standard deviation (SD) and range or as median and interquartile range, as appropriate. The Student t-test and the MannWhitney U-test were used to compare continuous variables, as appropriate. The Pearson chi-square test was used to compare categoric variables. Local recurrence rate, PFS, and CSS were the main outcomes of this study. The KaplanMeier method was used to calculate survival functions, and differences were assessed with the log rank statistic. Univariate and multivariate Cox regression models addressed time to cancer-specific mortality after surgery. Patients alive and free of disease or patients who died of other causes were censored. Statistical significance in this study was set as P = 0.05. All reported P values are two-sided.
RESULTS
RN was performed in 143 patients (30.1%), and TE was performed in the remaining 332 (69.9%). The clinical and pathologic characteristics of both groups of patients are summarized in Table 1 . Overall, 28 patients (8.4%) underwent TE for imperative indications. Patients who underwent traditional RN had symptomatic presentation in a higher percentage of cases (P \ 0.0001) compared with those receiving TE. There were no statistically significant differences between patients having RN and TE according to age at surgery and performance status ECOG score.
Mean clinical tumor size was significantly larger in the RN group (4.9 vs. 3.2 cm; P \ 0.0001).
According to pT stage, mean pathologic tumor size was slightly larger in patients who had RN in comparison to patients who had TE both for pT1a (3.3 vs. 2.8 cm; P \ 0.0001) and pT1b (5.6 vs. 5.0 cm; P \ 0.0001) tumors.
The surgical margin status of tumors that had TE was always negative.
The mean follow-up was 72 ± 44 months after RN and 58 ± 38 months after TE (P = 0.0004).
At last follow-up, 393 patients (82.7%) were alive and free of disease, and 56 (11.8%) had died of other causes. Overall, 26 patients (5.4%) experienced progressive disease; of these, 5 were alive but with disease progression (1%), and 21 (4.4%) had died of metastatic disease. No local recurrences were observed in the patients who underwent RN. Overall, 3 patients with pT1a RCC developed isolated renal recurrence after TE, and this was always elsewhere in the kidney. Specifically, all patients diagnosed as having local recurrence had negative surgical margins.
The 5-and 10-year overall survival estimates were 81.3 and 71.5% after RN and 82.9 and 71.9% after TE (P = NS), respectively.
The 5-and 10-year PFS estimates were 91.3 and 88.7% after RN and 95.3 and 92.8% after TE (P = NS), respectively (Fig. 1a) .
The 5-and 10-year CSS estimates were 92.1 and 89.4% after RN and 94.4% (5-and 10-year CSS) after TE (P = NS), respectively (Fig. 1b) . No statistically significant differences between RN and TE were found after adjusting CSS probabilities according to age at surgery of B65 year (log rank P = 0.99); or [65 years (log rank P = 0.14), according to Fuhrman nuclear grades 1-2, grade 3 or grade 4 (log rank P = 0.48, log rank P = 0.89, log rank P = 0.62, respectively; Fig. 1c) , or according to pT1a or pT1b (log rank P = 0.46, log rank P = 0.44, respectively; Fig. 1d) . No statistically significant differences between RN and TE were found in the subgroup of clear cell RCCs that represented the 78.6% of the entire case series (log rank P = 0.37). Tables 2 and 3 summarize the results of Cox univariate analyses for PFS and CSS, respectively. Surgical treatment was not a predictor of PFS and CSS at univariate analyses. Multivariate analyses for PFS and CSS by Cox regression methods showed that Fuhrman nuclear grade (P \ 0.001) was the only independent predictor of PFS and CSS. Conversely, surgical technique, pathologic tumor dimensions, and symptomatic presentation were not statistically significant (Tables 4 and 5 ).
DISCUSSION
In recent years, PN has become the standard surgical treatment for T1a renal tumors (\4 cm) and select T1b tumors (4-7 cm); large retrospective series with a long follow-up have showed that TE can achieve similar oncologic results. [1] [2] [3] [4] [5] [6] [7] [8] 11, 12 Ideally, every surgical option for the treatment of renal tumors should be compared to RN, which has the longest follow-up and robust data regarding oncologic outcome. However, RN is no longer considered the first surgical option for the treatment of intracapsular renal tumors because it invariably leads to a substantial decrease in the number of glomeruli and is associated with an increase in cardiovascular events and mortality compared with PN. 19, 20 For these reasons, at present, it is almost impossible to conduct a prospective randomized study to compare TE and RN. Indeed, the only randomized study comparing the oncologic outcome of elective PN and RN for low-stage RCC (EORTC Intergroup phase 3 trial 30904) began in April 1992 and was prematurely closed in January 2003 because of poor accrual. 21 Our study represents the first large single-center, nonrandomized analysis that aims to compare the oncologic outcomes of TE versus RN in pT1 RCC. Our main conclusion is that TE produces oncologic outcomes equivalent to RN. Nevertheless, there are still some criticisms against TE that rise from the evidence that a ''minimal'' rim of normal parenchyma around the resected tumor is recommended to ensure a complete tumor removal and reduce the risk of local relapse or progression and from the evidence that the tumor capsule that serves as a landmark for TE will be missing in some tumors. 22 In particular, Saranchuk et al. presented the experience of nephron-sparing surgery in 54 patients with a solitary kidney at the Memorial Sloan-Kettering Cancer Center between 1989 and 2003. 23 The tumor was resected with PN in 45 cases, and TE was used in 9 cases. The overall positive surgical margins rate was quite high at 15%. According to the surgical technique adopted, 33 and 11% of the patients had positive surgical margins after TE and PN, respectively. Only one of the six patients who died from disease had positive surgical margins (a patient with stage M1 disease who had both local and distant recurrence nearly 4 months after PN). The authors of the study concluded that most of the TE cases were performed during the early part of their study period, and they no longer routinely use TE for such patients. 23 Other series of TE reported a far lower rate of positive surgical margins comparable to those reported in PN series or even lower than those reported after standard PN. A recent multi-institutional project analyzed the surgical and oncologic outcome of 1519 patients treated by standard PN (982 patients) or by TE (537 patients) and reported a lower rate of positive surgical margins in the TE group in comparison with the standard PN group (0.2 vs. 3.4%). 24 Touijer et al., in a recent collaborative review, criticized the oncologic safety of TE above all for the treatment of T1b tumors. 8 In this category of patients, the PFS reported by Carini et al. after TE seems to be slightly worse in comparison with those reported by other authors who used traditional PN. [3] [4] [5] [6] 12 However, the observed differences can be explained considering the potential different selection criteria adopted in the available studies. In the series by Carini et al., 43% of patients who had kidney surgery for pathologically confirmed 4-7 cm RCC received TE compared with 10.1% of conservative treatments versus RN in a large multicenter series by Patard et al. and with 10.8% in a recent series of the Mayo Clinic, respectively. 3, 4, 12 Moreover, in the series by Carini et al., the analysis was not limited to elective cases, as in other series. 
to type of surgery adopted. b KaplanMeier CSS estimates according to type of surgery adopted. c Kaplan-Meier CSS estimates according to type of surgery adopted in patients with G1-2, G3, and G4 RCC. d KaplanMeier CSS estimates according to type of surgery adopted in patients with pT1a and pT1b RCC Our results showed that TE can achieve similar oncologic results to RN in different CSS subanalyses: pT1a, pT1b, clear cell RCCs, and patients with age at surgery of B65 and [65 years. Moreover, no statistically significant differences between RN and TE were found after adjusting CSS probabilities according to Fuhrman nuclear grade 1-2 and grade 3. Too few grade 4 RCCs were included to enable us to reach statistically significant conclusions.
Cox univariate analyses for PFS and CSS confirmed that the surgical treatment was not influencing the oncologic outcome in the entire series, and surgical treatment was also not an independent predictor of PFS and CSS in a multivariate analysis that showed Fuhrman nuclear grade (P \ 0.001) to be the only independent predictor of survival.
A recent prospective study based on pathologic examination of the surgical specimen obtained after TE provided the pathologic rationale of TE. 25 Specifically, this study described the presence a continuous, fibrous capsule composed of dense connective fibrous tissue in all 90 RCC tumors, surrounded by healthy tissue with a median thickness of 1 mm with signs of chronic inflammation. 25 This microscopic layer of renal parenchyma allows the presence of negative surgical margins in patients with tumors extending beyond the capsule and make it possible to consider TE as a minimal PN. [25] [26] [27] Moreover, the TE technique, resecting no renal parenchyma around the tumor, causes the slightest unnecessary deepening of the excision in healthy tissues, resulting in a lower theoretical risk of postoperative bleeding and laceration of the urinary collecting system that can cause the development of urinary fistulas. 28 We acknowledge several strengths to but also some limitations of the present study. This study represents the first large single-center, nonrandomized analysis aiming to compare the oncologic outcomes of TE versus RN in pT1 RCC. The main limitations of the present study are inherent to its retrospective nature; specifically, the choice between TE and RN was based on tumor location and surgeon preference, which resulted in unbalanced clinical and pathologic characteristics between the two group. Also, patients who had TE for imperative indications were included in the study because excluding them from the comparative analysis would have favored the oncologic results of TE against RN, resulting as a further bias of the study. Moreover, although the multivariate analyses adjusted for the different case mix, a prospective randomized study would clearly yield stronger evidence. This comparative study between TE and RN showed that the two procedures produced similar oncologic outcomes in terms of PFS and CSS estimates. Therefore, TE can be regarded as a valid option in the surgical treatment of patients suitable for conservative therapy both for T1a and T1b tumors. Multivariate analysis showed that in pT1 tumors, a worse prognosis was correlated with nuclear grade. Conversely, the surgical approach did not influence survival in this category of patients. 
